Pureprofile Ltd (ASX:PPL) is a data analytics and consumer insights company underpinned by proprietary technology, servicing business decision makers in brands and media companies as well as market researchers. Pureprofile has released its well-flagged H1 FY26 accounts in which it notably reported H1 FY26 adjusted NPAT of $2.41m, up 30% on the previous corresponding period (pcp) and well ahead of our forecast for $0.9m. Reported NPAT was $1.9m, up 22% on the pcp. As previously reported by the company, Pureprofile delivered a 14% increase in H1 FY26 revenue to $33.3m and a 14% increase in adjusted EBITDA to $3.8m. The company also reiterated its FY26 guidance for revenue in the range of $64m to $65m and an EBITDA margin of 10% to 11%. We have made small changes to our FY26 forecasts, having previously incorporated the recently announced CRNRSTONE acquisition, and note that our revisions bring our FY26 EBITDA margin forecast to 10.2%, at the lower end of the guidance range. Our DCF valuation of $0.12/share remains unchanged and implies 179% potential capital upside on the current share price.
02 Mar 2026
Adjusted NPAT ahead of forecasts and up 30%
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Adjusted NPAT ahead of forecasts and up 30%
Pureprofile Ltd. (PPL:ASX) | 0 0 -1.1% | Mkt Cap: 10.7m
- Published:
02 Mar 2026 -
Author:
Finola Burke -
Pages:
6 -
Pureprofile Ltd (ASX:PPL) is a data analytics and consumer insights company underpinned by proprietary technology, servicing business decision makers in brands and media companies as well as market researchers. Pureprofile has released its well-flagged H1 FY26 accounts in which it notably reported H1 FY26 adjusted NPAT of $2.41m, up 30% on the previous corresponding period (pcp) and well ahead of our forecast for $0.9m. Reported NPAT was $1.9m, up 22% on the pcp. As previously reported by the company, Pureprofile delivered a 14% increase in H1 FY26 revenue to $33.3m and a 14% increase in adjusted EBITDA to $3.8m. The company also reiterated its FY26 guidance for revenue in the range of $64m to $65m and an EBITDA margin of 10% to 11%. We have made small changes to our FY26 forecasts, having previously incorporated the recently announced CRNRSTONE acquisition, and note that our revisions bring our FY26 EBITDA margin forecast to 10.2%, at the lower end of the guidance range. Our DCF valuation of $0.12/share remains unchanged and implies 179% potential capital upside on the current share price.